"Eye Care" adds vision to the new vision and astigmatism to correct the monolithic intraocular lens
Taiwan·Risk Class 3·Johnson & Johnson surgical Vision, Inc.;; AMO PUERTO RICO MANUFACTURING, INC.·Registered Jun 09, 2020 – Jun 09, 2025Expired- Analysis ID
- f0dc857e4dddace0001b166efc414663
- Customs Code
- DHA05603375806
- Manufacturer Country
- United States
- Authorized Representative
- AMO ASIA LIMITED, TAIWAN BRANCH (HONG KONG)
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- M Ophthalmology
- Product Type (Level 2)
- M.3600 Artificial Crystal
- Import Information
- Input;; Contract manufacturing
- Registration Date
- Jun 09, 2020
- Expiry Date
- Jun 09, 2025
Top companies providing products similar to ""Eye Care" adds vision to the new vision and astigmatism to correct the monolithic intraocular lens"
Recently registered similar products
Access comprehensive regulatory information for "Eye Care" adds vision to the new vision and astigmatism to correct the monolithic intraocular lens in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number f0dc857e4dddace0001b166efc414663 and manufactured by Johnson & Johnson surgical Vision, Inc.;; AMO PUERTO RICO MANUFACTURING, INC.. The authorized representative in Taiwan is AMO ASIA LIMITED, TAIWAN BRANCH (HONG KONG).
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Johnson & Johnson Surgical Vision, Inc.;; AMO Groningen B.V., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.